Polyrizon Ltd. (PLRZ) stock
PLRZNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$10.65−0.05 (-0.47%)
Close on Nov 17, 2026Market cap $17.13MP/E 2.2Yield –
Polyrizon r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2025 it was $2.13M, up 299.4% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.13M | +299.4% |
| FY2024 | Dec 31, 2024 | $534.00K | +60.8% |
| FY2023 | Dec 31, 2023 | $332.00K | -4.3% |
| FY2022 | Dec 31, 2022 | $347.00K | – |
See a number that looks wrong?